Percheron Therapeutics (AU:PER) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Percheron Therapeutics has announced a change in the interest of its director, James Garner, who acquired 3 million unquoted options, exercisable at 8.3 cents per option by July 2029. This acquisition, approved at the recent Annual General Meeting, could influence investor sentiment and the company’s market activity.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.
